Atlas Trials

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

Clinical trial NCT02526745 · COMPLETED

Trial details

NCT number
NCT02526745
Sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2015-12-01
Primary completion
2016-07-01
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.